Home   >  
Cell Cycle/DNA Damage
  • Epigenetics
∨
  >  
PARP

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

PARP

Chemical Structure Cat. No. Product Name CAS No.
GeA-69 Chemical Structure
 BCP31007 GeA-69 2143475-98-1
GeA-69 is a novel selective allosteric inhibitor targeting macrodomain 2 of poly-adenosine-diphosphate-ribose polymerase 14.
BSI-401 Chemical Structure
 BCP27642 BSI-401 142404-10-2
BSI-401 is a novel PARP-1 inhibitor with both oral bioavailability and strong antitumor potency.
RK-287107 Chemical Structure
 BCP30401 RK-287107 2171386-10-8
RK-287107 is a potent TNKS/TNKS2 inhibitor (IC50 = 14.4 nM) with >7000-fold selectivity against the PARP1 enzyme, which inhibits WNT-responsive TCF reporter activity and proliferation of human colorectal cancer cell line COLO-320DM.
Rivoglitazone Chemical Structure
 BCP06166 Rivoglitazone 185428-18-6
Rivoglitazone is an agent belonging to the glitazone class of antidiabetic agents with antihyperglycemic activity.
NU 1025 Chemical Structure
 BCP27646 NU 1025 90417-38-2
NU1025 is a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP). Ki and IC50 values are 48 and 400 nM respectively.
3-Aminobenzamide Chemical Structure
 BCP27669 3-Aminobenzamide 3544-24-9
3-Aminobenzamide is a competitive PARP inhibitor with Ki of 1.8 μM.
ME-0328 Chemical Structure
 BCP28104 ME-0328 1445251-22-8
ME0328 is a potent and selective ARTD3/PARP3 inhibitor with an IC50 of 0.89±0.28 μM.
Niraparib metabolite M1 Chemical Structure
 BCP24851 Niraparib metabolite M1 1476777-06-6
Niraparib metabolite M1 is a metabolite of niraparib, and the latter one acts as a novel poly(ADP-Ribose) polymerase (PARP) inhibitor.
Niraparib Tosylate Monohydrate Chemical Structure
 BCP25472 Niraparib Tosylate Monohydrate 1613220-15-7
Niraparib Tosylate Monohydrate is an orally bioavailable, hydrated, tosylate salt form of niraparib, an inhibitor of poly (ADP-ribose) polymerase (PARP) types 1 and 2 (PARP-1 and -2), with antineoplastic activity.
JPI-289 2HCl.2H2O Chemical Structure
 BCP29656 JPI-289 2HCl.2H2O 1449233-60-6
JPI-289 hydrochloric hydrate is a novel potent, water soluble PARP-1 inhibitor with IC50 of 18.5 nM, inhibits cellular PAR formation with IC50 of 10.7 nM.
123下一页末页共 40 条记录 1 / 4 页 
0086-13720134139